{"id":56343,"name":"TERUMO BCT, INC.","slug":"terumo-bct-inc","state":"CO","country":"United States of America","description":"Medical technology company","totalSpending":690000,"filings":10,"yearlySpending":[{"year":2023,"income":360000},{"year":2024,"income":250000},{"year":2025,"income":80000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MAN","display":"Manufacturing"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["TERUMO BCT, INC."],"lobbyists":["ANDREA HECHAVARRIA","LATOYA THOMAS"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Environmental Protection Agency (EPA)","White House Office","Office of Management & Budget (OMB)","Bureau of Industry and Security (BIS)"],"sampleDescriptions":["medical device manufacturing health care technology health care access","medical device manufacturing health care technology health care access","medical device manufacturing health care technology health care access","medical device manufacturing health care technology health care access","-Access to Therapeutic Apheresis, generally. -Sickle Cell Disease issues, generally; S.1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment A"]}